The 11 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 500.00, with a high estimate of 595.00 and a low estimate of 370.00. The median estimate represents a +33.60% increase from the last price of 374.26.
The current consensus among 12 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.85
Reporting Date Nov 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.